How to Take This Medicine

For adults and adolescents, the standard dosage is one tablet daily. Adhere to the guidance given and continue using Abacavir/Lamivudine Viatris until your healthcare provider advises you to discontinue.

Side Effects

If you experience any other symptoms that might be affecting your well-being, please inform your healthcare provider or pharmacist. It’s important to note that there could be additional side effects not mentioned here that some individuals might encounter.

Important Warnings

Do not take ABACAVIR/LAMIVUDINE VIATRIS if you have ever experienced an allergic reaction to abacavir. Additionally, avoid this medication if you are allergic to lamivudine or any other components listed at the end of this leaflet. Always verify the ingredients to ensure this medicine is safe for you.

If you suffer from severe liver disease, ABACAVIR/LAMIVUDINE VIATRIS might not be appropriate for you. Similarly, those with significant kidney issues should exercise caution. Inform your healthcare provider about any other medical conditions you have, any medications you are currently taking, and any allergies to medicines, foods, preservatives, or dyes.

During treatment, there is a possibility of developing certain side effects. Understanding these risks and knowing how to monitor them is crucial. Refer to Section 6 for more details on potential side effects.

Consult your doctor if you are pregnant, planning to become pregnant, breastfeeding, or considering breastfeeding. Do not use ABACAVIR/LAMIVUDINE VIATRIS tablets during pregnancy or while breastfeeding unless your doctor advises otherwise.

When starting any new medication, remind your doctor and pharmacist that you are taking ABACAVIR/LAMIVUDINE VIATRIS. Inform any other healthcare professionals, including dentists and pharmacists, that you are on this medication. If you are scheduled for surgery, notify the surgeon or anesthetist, as this medicine may interact with other drugs used during the procedure.

If you become pregnant while using this medication, contact your doctor immediately. Attend all scheduled appointments to monitor your progress. If you stop taking ABACAVIR/LAMIVUDINE VIATRIS for any reason, consult your doctor before resuming, especially if you suspect side effects or have another illness. In some cases, your doctor may recommend restarting the medication where medical assistance is readily available.

ABACAVIR/LAMIVUDINE VIATRIS contains abacavir, which can cause a severe allergic reaction known as hypersensitivity. This reaction can be life-threatening if treatment with abacavir-containing products is not discontinued. Research indicates that individuals with the HLA-B (type 5701) gene are more susceptible to this reaction. However, even without this gene, the risk remains. If you are aware of having this gene, inform your doctor before taking abacavir.

Common symptoms of this reaction include fever and skin rash. Other frequently observed symptoms are nausea, vomiting, diarrhea, abdominal pain, extreme fatigue, body aches, general malaise, headache, shortness of breath, sore throat, or cough. If you experience any of these symptoms, contact your doctor immediately for advice on whether to stop taking ABACAVIR/LAMIVUDINE VIATRIS. If your doctor is unavailable, seek urgent medical advice, such as visiting the nearest hospital’s emergency department, before taking the next dose.

Additional symptoms may include joint or muscle pain, neck swelling, or itchy skin. Occasionally, eye inflammation (conjunctivitis), mouth ulcers, tingling or numbness in the hands or feet, or low blood pressure may occur. These allergic reaction symptoms can arise at any point during treatment, typically within the first six weeks, and may worsen with continued use.

If you have experienced this severe reaction to ABACAVIR/LAMIVUDINE VIATRIS, never take this medication or any other product containing abacavir again, as it may lead to a life-threatening drop in blood pressure or death within hours. In rare cases, life-threatening hypersensitivity reactions have occurred when the medication was restarted in patients who previously reported only one symptom on the Alert Card before stopping. On very rare occasions, hypersensitivity has been reported upon restarting the medication in patients who had no prior symptoms.

If you have discontinued ABACAVIR/LAMIVUDINE VIATRIS for any reason, it is crucial to consult your doctor before resuming, especially if you suspect side effects from other medications or have another illness. Your doctor will assess whether any previous symptoms were related to this hypersensitivity reaction. If there is a possibility, you may be advised never to take ABACAVIR/LAMIVUDINE VIATRIS again. It is vital to adhere to this guidance.

If you are hypersensitive to ABACAVIR/LAMIVUDINE VIATRIS, return any unused tablets to your doctor or pharmacist for proper disposal. Patients with moderate kidney disease should be closely monitored due to an increased risk of certain side effects.

Alcohol & Driving

Exercise caution when operating vehicles or handling machinery until you are aware of how ABACAVIR/LAMIVUDINE VIATRIS influences your abilities. Although there have been no specific studies conducted to assess the impact of ABACAVIR/LAMIVUDINE VIATRIS tablets on driving or machine operation, it is important to consider your overall health and any potential side effects from the medication before engaging in such activities.

Storage

Ensure your ABACAVIR/LAMIVUDINE VIATRIS tablets remain in their original packaging until you are ready to use them. They should be stored at temperatures below 25°C. Please adhere to the guidelines provided on the carton for proper medication care.

Keep the tablets in a cool, dry location, away from any moisture, heat, or direct sunlight. Avoid placing them in areas such as the bathroom, near a sink, inside a vehicle, or on window ledges. It’s essential to store them out of the reach of young children, ideally in a locked cabinet.

If the medication is no longer needed or has expired, take it to a pharmacy for safe disposal. Do not consume the medicine past its expiration date.

Product Details

The primary components of Abacavir/Lamivudine Viatris include 600 mg of abacavir in the form of its sulfate salt and 300 mg of lamivudine. These are the active ingredients responsible for the medication’s therapeutic effects.

In addition to the active ingredients, the tablets contain several inactive substances. These include microcrystalline cellulose, crospovidone, magnesium stearate, silicified microcrystalline cellulose, colloidal anhydrous silica, and talc. The tablets are coated with the OPADRY II complete film coating system 13B58894 White, which comprises hypromellose, titanium dioxide, macrogol 400, and polysorbate 80.

It is important to note that Abacavir/Lamivudine Viatris tablets contain sorbates and sulfites, which may trigger allergic reactions in some individuals. If you have a known allergy to any of these components, it is crucial to avoid taking this medication.